Racial disparities in gout and gout treatment are an ongoing but tractable problem, research at the 2025 American College of ...

Reversing the standard approved dose levels of nivolumab (Opdivo) and ipilimumab (Yervoy) in metastatic melanoma led to less ...

The rise in direct-to-patient therapeutics access via online compounding pharmacies and other direct-to-patient sales models has increased the likelihood of patients utilizing medications alongside ...

Here's why not charging is so bad. When a PHEV runs the battery to a low state of charge, it tries to charge itself back up.

Delandistrogene moxeparvovec, a gene therapy approved for the treatment of Duchenne muscular dystrophy (DMD), was found tolerable and showed signs of efficacy in a real-world cohort. Delandistrogene ...

Mepolizumab significantly reduced asthma exacerbations and oral corticosteroid use in patients with SEA, with or without CRSwNP, in a real-world setting. Improvements in lung function and asthma ...

The majority of patients with early-stage disease Alzheimer’s disease (AD) had stable or improved cognition over roughly 1 year of treatment with lecanemab (Leqembi), a real-world analysis showed. The ...

Artificial intelligence (AI) is increasingly used to analyze medical images, materials data and scientific measurements, but ...

Nivolumab plus ipilimumab shows promising real-world effectiveness in intermediate- or poor-risk mRCC, with median overall survival of 38.4 months and progression-free survival of 11.1 months.

Real-world studies assess treatment effectiveness and patient experience beyond clinical trial settings, considering broader patient populations. Clinical trials have stricter enrollment criteria, ...